LegislationMedical AMPersonalized Medicine

FDA establishes Additive Manufacturing Lab for medical devices

Program aims to enhance the FDA's readiness to handle issues in premarket and postmarket stages

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

The Additive Manufacturing Program in the FDA’s Center for Devices and Radiological Health (CDRH) researches the effects of innovative manufacturing technologies to help ensure patient access to medical devices that are safe and effective. Referred to as the FDA Additive Manufacturing Lab, this is one of 20 research programs in CDRH’s Office of Science and Engineering Laboratories (OSEL).

AM and medical devices

In the past decade additive manufacturing went from a niche manufacturing technology to the preferred manufacturing method for hearing aids and metal spine cages. To date, the FDA has cleared over 100 devices made using additive manufacturing technologies.

While there are several other orthopedic, dental, and diagnostic applications utilizing the technology, the full promise of additive manufacturing has not yet been realized by the broader medical device community. Despite the full adoption of additive manufacturing in some product areas, regulatory science research in this space will spur medical device design, materials, and manufacturing innovation.

FDA establishes Additive Manufacturing Lab for medical devices to enhance the FDA's readiness to handle issues in premarket and postmarket

Regulatory science gaps and challenges

The Additive Manufacturing Program is driven by several significant regulatory science gaps and challenges. Firstly, there is a considerable level of uncertainty surrounding the testing and validation of additive manufacturing processes, particularly in predicting the performance of medical devices. This uncertainty has hindered innovation, discouraged investments, and slowed down the adoption of additive manufacturing in the medical field. Secondly, additive manufacturing encompasses a wide spectrum of technologies involving hardware, software, and materials, all of which are continuously evolving.

This constant evolution necessitates ongoing adjustments in the specifics of process validation and regulatory review, creating an additional challenge. Thirdly, the simplicity of additive manufacturing has led clinicians and hospitals to explore its potential for manufacturing medical devices on-site, requiring guidance in this endeavor.

The overarching goal of the Additive Manufacturing Program is to address these knowledge gaps by promoting an understanding of how additive manufacturing technologies impact the evaluation of medical devices’ benefit-risk ratio. Additionally, it aims to enhance the FDA’s readiness to handle additive manufacturing-related issues in both the premarket and postmarket stages of the medical device lifecycle.

FDA Additive Manufacturing Lab activities

The Additive Manufacturing Program is dedicated to conducting regulatory science research in specific areas of interest. These include activities related to process validation and process monitoring for various advanced manufacturing technology types. Another key focus is addressing issues associated with compliance with quality system regulations, which entails devising efficient performance testing methods for evaluating lattice structures and identifying critical parameters for optimized topology.

Additionally, the program concentrates on developing software workflows that facilitate additive manufacturing, particularly in applications customized for individual patients. Those interested in further details and inquiries can contact the program at OSEL_additivemanufacturing@fda.hhs.gov.

Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based VoxelMatters. Today the company publishes the leading news and insights websites VoxelMatters.com and Replicatore.it, as well as VoxelMatters Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services


Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.